Graf Acquisition Corp. IV Uncategorized Contracts & Agreements
19 Contracts & Agreements
- Letter Agreement, dated April 28, 2024, by and between the Company and Sandia (Filed With SEC on April 29, 2024)
- Letter Agreement, dated April 28, 2024, by and between the Company and Meteora (Filed With SEC on April 29, 2024)
- Form of Lock-up Agreement, by and among certain stockholders of NKGen Biotech, Inc. and Graf Acquisition Corp. IV (Filed With SEC on October 19, 2023)
- NKGen Support Agreement, dated as of April 14, 2023, by and among Graf Acquisition Corp. IV and the stockholders of NKGen Biotech, Inc. named as parties thereto (Filed With SEC on October 19, 2023)
- Offer Letter, dated September 29, 2023 by and between James A. Graf and NKGen Biotech, Inc (Filed With SEC on October 5, 2023)
- Third Amended and Restated Sponsor Support and Lockup Agreement, dated September 29, 2023, by and among Graf Acquisition Corp. IV, NKGen Biotech, Inc., Graf Acquisition Partners... (Filed With SEC on October 5, 2023)
- Second Amended and Restated Sponsor Support and Lockup Agreement, dated as of September 28, 2023, by and among Graf Acquisition Corp. IV, NKGen Biotech, Inc., Graf Acquisition... (Filed With SEC on October 5, 2023)
- Letter Agreement, dated September 19, 2023, by and among Graf Acquisition Corp. IV and Meteora Capital Partners, LP and certain of its affiliates (Filed With SEC on October 5, 2023)
- Amended and Restated Sponsor Support and Lockup Agreement, dated as of September 21, 2023, by and among Graf, NKGen and certain directors of Graf (Filed With SEC on September 22, 2023)
- Form of Lockup Agreement (Filed With SEC on April 17, 2023)
- Backstop Agreement, dated as of April 14, 2023, by and among Graf Acquisition Corp. IV and NKMAX Co., Ltd (Filed With SEC on April 17, 2023)
- NKGen Support Agreement, dated as of April 14, 2023, by and among Graf Acquisition Corp. IV, and the stockholders of NKGen Biotech, Inc. named as parties thereto (Filed With SEC on April 17, 2023)
- Sponsor Support and Lockup Agreement, dated as of April 14, 2023, by and among Graf Acquisition Corp. IV, NKGen Biotech, Inc., Graf Acquisition Partners IV, LLC, and certain... (Filed With SEC on April 17, 2023)
- Description of Securities (Filed With SEC on March 31, 2022)
- Letter Agreement, dated July 14, 2021, by and between the Company and Alexandra Lebenthal (Filed With SEC on July 14, 2021)
- Letter Agreement, dated May 20, 2021, by and among the Company, its executive officers, its directors and Graf Acquisition Partners IV LLC (Filed With SEC on May 25, 2021)
- Form of Indemnity Agreement (Filed With SEC on May 5, 2021)
- Form of Letter Agreement among the Registrant and our officers, directors and Graf Acquisition Partners IV LLC (Filed With SEC on May 5, 2021)
- Specimen Unit Certificate (Filed With SEC on May 5, 2021)
